Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT00915798 Completed - Smoking Clinical Trials

Association Between Smoking, Brain Activity, Genes, and ADHD

Start date: July 2009
Phase: Phase 4
Study type: Observational

The study investigated the underlying mechanisms of smoking in young adults by examining the associations between smoking, brain activity, dopamine genes, and attention deficit hyperactivity disorder (ADHD).

NCT ID: NCT00912795 Completed - Smoking Clinical Trials

SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation

SMS Turkey
Start date: January 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to develop and test a text messaging-based smoking cessation program for adults who are currently smoking and want to quit, living in Turkey.

NCT ID: NCT00906386 Enrolling by invitation - Smoking Clinical Trials

Methadone Maintenance Treatment and Smoking Cessation

MMTASC
Start date: May 2009
Phase: Phase 2
Study type: Interventional

The main hypotheses guiding the study are: 1. Stable methadone maintenance patients receiving varenicline will be more likely to maintain abstinence than patients receiving placebo 2. There will be no differences in the type and number of symptoms reported between stable methadone maintenance patients receiving varenicline and placebo 3. There will be no changes in methadone dosage between abstinent and non-abstinent smokers 4. There will be no differences in efficacy, withdrawal symptoms, and safety of varenicline between male and female participants

NCT ID: NCT00884013 Completed - Hypertension Clinical Trials

New York City (NYC) Health eHearts Pay for Quality Pilot

ehearts
Start date: January 2009
Phase: N/A
Study type: Observational

Do monetary incentives in small independent primary care practices improve the delivery of preventive services as recommended by U.S. Preventive Services Task Force (USPSTF) guidelines for cardiovascular health?

NCT ID: NCT00882336 Completed - Obesity Clinical Trials

European Study of Cardiovascular Risk

EURIKA
Start date: May 2009
Phase: N/A
Study type: Observational

The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries. The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office. Study variables will be measured: - By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication. - By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment. - By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured. - CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.

NCT ID: NCT00862927 Terminated - Smoking Clinical Trials

Cue Reactivity in Virtual Reality: The Role of Context

Start date: March 2009
Phase: N/A
Study type: Observational

The objectives of this proposal are to examine the role of context in a virtual reality (VR) environment and to explore the extent to which cues (i.e., contextual cues or explicit smoking cues) influence craving and physiological arousal within VR. The current study seeks to determine whether smokers, placed in the context of a VR convenience store devoid of explicit smoking cues, will experience less craving and physiological arousal, compared to exposure to the same VR environment containing explicit smoking cues. This important line of inquiry will help clarify the influence of environmental contexts that may contribute to the overall reactivity effects (e.g., craving, arousal) smokers experience when confronted with cues associated with smoking.

NCT ID: NCT00860028 Completed - Smoking Clinical Trials

Varenicline for Smoking Cessation in Heavy Drinking Smokers

Start date: October 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether extended pretreatment with varenicline (Chantix) is more efficacious for smoking cessation than standard pretreatment, how well varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol consumption.

NCT ID: NCT00846339 Completed - Smoking Clinical Trials

PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration

Start date: November 2008
Phase: Phase 4
Study type: Interventional

Bupropion has different effects on D2 dopamine receptors according to genotype.

NCT ID: NCT00843505 Completed - Smoking Clinical Trials

Evaluating a Telemedicine Smoking Cessation Program in Rural Primary Care Practices

Start date: June 2009
Phase: Phase 3
Study type: Interventional

People who smoke cigarettes and live in rural areas may not have access to a wide variety of resources to help them stop smoking. This study will evaluate two smoking cessation programs—an Internet-based telemedicine program and a telephone-based quitline program—among rural residents.

NCT ID: NCT00836199 Completed - Smoking Cessation Clinical Trials

NicVAX/Placebo as an Aid for Smoking Cessation

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.